No clinical advantage of combination antidepressant treatment over monotherapy
Prenatal SSRI exposure unlikely to be major risk factor for autism
Aripiprazole and restless legs syndrome
Switching from antipsychotic polypharmacy to monotherapy
Pregabalin possibly useful for social anxiety disorder
Short-term benefits of add-on gabapentin with naltrexone
Atypical antipsychotics for posttraumatic stress
Varenicline for smokers and cardiovascular risk
Fluvoxamine and long QTU syndrome